Risk tables for parkinsonism and Parkinson's disease

被引:265
|
作者
Elbaz, A
Bower, JH
Maraganore, DM
McDonnell, SK
Peterson, BJ
Ahlskog, JE
Schaid, DJ
Rocca, WA
机构
[1] Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Neurol, Rochester, MN 55905 USA
关键词
parkinsonism; Parkinson's disease; epidemiology; lifetime risk; cumulative risk; competing risks;
D O I
10.1016/S0895-4356(01)00425-5
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
We applied the incidence rates of parkinsonism and Parkinson's disease (PD) from Olmsted County, MN (1976-1990) to a hypothetical cohort undergoing the mortality rates observed in Minnesota, and computed the lifetime risk and the remaining lifetime risk of developing parkinsonism and PD. These risks were compared to cumulative incidences that do not take competing risks of death into account. The lifetime risk of developing parkinsonism from birth was 4.4% for men and 3.7% for women (ratio = 1.2). The corresponding risk of developing PD was 2.0% for men and 1.3% for women (ratio = 1.5). Because of the opposite effect of higher incidence and higher mortality rates in men, the lifetime risks were only slightly higher in men than in women. Lifetime cumulative incidences were consistently higher than lifetime risks; this difference was more pronounced in men and in older subjects. Lifetime risk estimates are useful in clinical practice, epidemiologic research, and public health. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:25 / 31
页数:7
相关论文
共 50 条
  • [31] MPTP Parkinsonism and Implications for Understanding Parkinson's Disease
    AlShimemeri, Sohaila
    Di Luca, Daniel G.
    Fox, Susan H.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2022, 9 (01): : 42 - 47
  • [32] Parkinson's disease, parkinsonism, and traumatic brain injury
    Wong, Janice C.
    Hazrati, Lili-Naz
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2013, 50 (4-5) : 103 - 106
  • [33] Manganese-induced parkinsonism and Parkinson's disease
    Olanow, CW
    REDOX-ACTIVE METALS IN NEUROLOGICAL DISORDERS, 2004, 1012 : 209 - 223
  • [34] Autonomic dysfunction in Parkinson's disease and vascular parkinsonism
    Murata, Y
    Harada, T
    Ishizaki, F
    Izumi, Y
    Nakamura, S
    ACTA NEUROLOGICA SCANDINAVICA, 1997, 96 (06): : 359 - 365
  • [35] Diagnosis and differential diagnosis of Parkinson's disease and parkinsonism
    Ahlskog, JE
    PARKINSONISM & RELATED DISORDERS, 2000, 7 (01) : 63 - 70
  • [36] MRI Signs of Parkinson's Disease and Atypical Parkinsonism
    Aludin, Schekeb
    Schmill, Lars-Patrick Andreas
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 2021, 193 (12): : 1403 - 1409
  • [37] Risk of Parkinson Disease and Secondary Parkinsonism in Myocardial Infarction Survivors
    Sundboll, Jens
    Szepligeti, Szimonetta Komjathine
    Szentkuti, Peter
    Adelborg, Kasper
    Horvath-Puho, Erzsebet
    Pedersen, Lars
    Henderson, Victor W.
    Sorensen, Henrik Toft
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (05):
  • [38] Prevalence of Parkinson's disease and other types of Parkinsonism -: A door-to-door survey in Bidasoa, Spain
    Bergareche, A
    De la Puente, E
    de Munain, AL
    Sarasqueta, C
    de Arce, A
    Poza, JJ
    Martí-Massó, JF
    JOURNAL OF NEUROLOGY, 2004, 251 (03) : 340 - 345
  • [39] Parkinsonism and Parkinson's disease associated with long-term administration of sertraline
    Latorre, MAP
    Modrego, PJ
    Rodilla, F
    Catalán, C
    Calvo, M
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2001, 26 (02) : 111 - 112
  • [40] Prevalence of Parkinson's disease and other types of parkinsonism in the Aeolian Archipelago, Sicily
    Morgante, L.
    Nicoletti, A.
    Epifanio, A.
    Contrafatto, D.
    Savica, R.
    Lanzafame, S.
    Musolino, R.
    La Spina, P.
    Bonuccelli, U.
    Marconi, R.
    D'Amelio, M.
    Savettieri, G.
    Zappia, M.
    PARKINSONISM & RELATED DISORDERS, 2008, 14 (07) : 572 - 575